Related Experiment Videos
Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents
C Fertin1, J F Nicolas, P Gillery
1Laboratoire de Biochimie, CNRS URA 610, Faculté de Médecine, Reims, France.
Insights
Interleukin-4 (IL-4) significantly boosts collagen synthesis in human skin fibroblasts, a key factor in fibrotic diseases. This finding highlights IL-4
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Background:
- Fibrosis involves inflammatory cells like T-lymphocytes and mast cells accumulating in connective tissues.
- Interleukin-4 (IL-4) is a product of these inflammatory cells.
- Understanding IL-4's role in fibrosis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the effects of Interleukin-4 (IL-4) on human fibroblast collagen synthesis.
- To compare IL-4's efficacy with Transforming Growth Factor beta (TGF-β) in stimulating collagen production.
- To assess IL-4's impact on fibroblast-mediated dermal equivalent contraction and proliferation.
Main Methods:
- Human fibroblasts from normal and scleroderma skin were cultured in three-dimensional collagen lattices (dermal equivalents).
- Dermal equivalents were treated with varying concentrations of IL-4 (10 and 100 U/ml).
- Collagen synthesis, lattice retraction, and cell proliferation were measured.
Main Results:
- IL-4 dose-dependently stimulated collagen synthesis in human fibroblasts.
- No significant changes in lattice retraction or cell proliferation were observed.
- At 100 U/ml, IL-4 was approximately twice as effective as TGF-β (10 ng/ml) in promoting collagen synthesis.
Conclusions:
- IL-4 is a potent stimulator of collagen synthesis in dermal fibroblasts.
- IL-4 may play a significant role in the pathogenesis of fibrotic conditions like scleroderma.
- Targeting IL-4 could be a therapeutic strategy for fibrotic diseases.
Abstract:
Interleukin-4 (IL-4) is one of the products of T-lymphocytes and mast cells, inflammatory cells which accumulate in connective tissues at early stages of fibrosis. We tested the effects of IL-4 on human fibroblasts from normal and scleroderma skin seeded in three dimensional collagen lattices ("dermal equivalents"). IL-4 (10 and 100 U/ml) stimulated collagen synthesis in a dose-dependent manner. No significant alteration of lattice retraction and cell proliferation was observed. At the concentration 100 U/ml, Il-4 was approximately twice more efficient on collagen synthesis than Transforming Growth Factor beta (10 ng/ml). IL-4 secretion in connective tissues might be an important factor for the development of fibrotic processes.